Differential effects of mu and kappa opioid systems on motivational processes
- PMID: 2829003
Differential effects of mu and kappa opioid systems on motivational processes
Abstract
The role of multiple opioid receptor types in mediating the motivational properties of opioid agonists and antagonists was investigated by means of a place-preference conditioning procedure. Mu-agonists produced positive reinforcing effects in drug-naive animals whereas kappa agonists and the opioid antagonist, naloxone, were aversive. Chronic infusion of naloxone during conditioning, at a dose sufficient to block mu- but not kappa-receptors, antagonized the effects of both morphine and naloxone. This treatment did not alter the aversion produced by the kappa agonist, U69593. These data demonstrate that opioid reinforcement results from an activation of mu-receptors whereas aversive effects are produced by either an antagonist action at this receptor or an activation of kappa receptors. Such results indicate that mu and kappa opioid systems differentially modulate motivational processes.
Similar articles
-
Motivational effects of opioids: influence of D-1 versus D-2 receptor antagonists.Eur J Pharmacol. 1988 Jul 7;151(2):233-42. doi: 10.1016/0014-2999(88)90803-5. Eur J Pharmacol. 1988. PMID: 2844553
-
Influence of chronic lithium treatment upon the motivational effects of opioids: alteration in the effects of mu- but not kappa-opioid receptor ligands.J Pharmacol Exp Ther. 1991 Mar;256(3):1101-6. J Pharmacol Exp Ther. 1991. PMID: 1848627
-
Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of mu- and kappa-opioid agonists.Brain Res. 1987 Dec 8;436(1):169-72. doi: 10.1016/0006-8993(87)91571-x. Brain Res. 1987. PMID: 2961413
-
Motivational effects of opioids: evidence on the role of endorphins in mediating reward or aversion.Pharmacol Biochem Behav. 1985 Nov;23(5):877-81. doi: 10.1016/0091-3057(85)90086-3. Pharmacol Biochem Behav. 1985. PMID: 3909169 Review.
-
Conditioning of opioid reinforcement: neuroanatomical and neurochemical substrates.Ann N Y Acad Sci. 1992 Jun 28;654:347-56. doi: 10.1111/j.1749-6632.1992.tb25980.x. Ann N Y Acad Sci. 1992. PMID: 1321576 Review. No abstract available.
Cited by
-
NCP, a Dual Kappa and Mu Opioid Receptor Agonist, Is a Potent Analgesic Against Inflammatory Pain without Reinforcing or Aversive Properties.J Pharmacol Exp Ther. 2024 Mar 15;389(1):106-117. doi: 10.1124/jpet.123.001870. J Pharmacol Exp Ther. 2024. PMID: 38409113 Free PMC article.
-
Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.J Neurosci. 2018 Sep 12;38(37):8031-8043. doi: 10.1523/JNEUROSCI.0653-18.2018. Epub 2018 Aug 3. J Neurosci. 2018. PMID: 30076211 Free PMC article.
-
Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.J Neurosci. 2015 Sep 16;35(37):12917-31. doi: 10.1523/JNEUROSCI.2444-15.2015. J Neurosci. 2015. PMID: 26377476 Free PMC article.
-
Two short-acting kappa opioid receptor antagonists (zyklophin and LY2444296) exhibited different behavioral effects from the long-acting antagonist norbinaltorphimine in mouse anxiety tests.Neurosci Lett. 2016 Feb 26;615:15-20. doi: 10.1016/j.neulet.2016.01.017. Epub 2016 Jan 15. Neurosci Lett. 2016. PMID: 26780565 Free PMC article.
-
Bis-Cyclic Guanidine Heterocyclic Peptidomimetics as Opioid Ligands with Mixed μ-, κ- and δ-Opioid Receptor Interactions: A Potential Approach to Novel Analgesics.Int J Mol Sci. 2022 Aug 25;23(17):9623. doi: 10.3390/ijms23179623. Int J Mol Sci. 2022. PMID: 36077029 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials